Latest News  

New Insights & Approvals for Baricitinib

New research shows that baricitinib is a safe and effective RA treatment. The medication has also been approved for use in Japan and is recommended for use in the U.K… [Read More]

Rituximab May Help Pediatric Patients with SLE

Although rituximab is not indicated for adults with SLE, a recent review suggests that it may be safe and effective for treating pediatric SLE. The review found that rituximab improved renal function and reduced proteinuria in pediatric patients. It may also prevent relapse and improve disease activity… [Read More]

2 Biosimilars Make Their Way Toward the European Market

Two biosimilar treatments, Rixathon and Imraldi, are moving closer to market release in Europe for the treatment of rheumatic and other diseases… [Read More]

Drug Tapering: Studies Point to Success in Some Patients

Highlights from the 2017 EULAR Congress MADRID—Scores on the Health Assessment Questionnaire for Rheumatoid Arthritis (HAQ) and C-reactive protein (CRP) levels were independent predictors of… [Read More]

Immune Response to Trauma May Flag Impending Organ Failure

NEW YORK (Reuters Health)—Early immune response signatures in the critically injured may shed light on mechanisms underlying multiple organ system failure, according to U.K. investigators…. [Read More]

U.S. Republicans Left Scrambling After Healthcare Bill Sinks Again

WASHINGTON (Reuters)—The collapse of Republicans’ push to repeal and replace Obamacare in the U.S. Senate set up a possible repeal-only vote and clouded the path… [Read More]

View More Latest News »